Browse funders

…rbon footprint within the healthcare setting. Aligning with the Trust’s Sustainable Development Strategy of setting a carbon neutrali…

…mpared direct and indirect costs of IV-IFX and SC-IFX, covering NHS, Trust and family costs. Environmental impact was estimated bas…

…im was to evaluate all NJ insertion procedures performed in the trust to identify features associated with successful tube insertion,…

…ble timely clinical interventions to reduce adverse outcomes. 1 NICE also highlighted the need for further evidence regarding diagno…

…Trust and community engagement will be as important as vaccines in co…

…h the expiration of patents on several high-cost biologics, the NHS has prioritised the integration of biosimilars to reduce pharma…

…e 36 hour trough gentamicin levels in 61% of patients.Reference National Institute for Health and Care Excellence. NG195. Neonatal infection: antibiotics for prevention and trea…

…or this audit. Eligible patients included those born within the Trust, extremely premature, and received SCAMP during this period. Pa…

…nt.Conclusions The PEAR has become an essential tool within our Trust, supporting pharmacists and clinicians in making informed clini…

…tifying patients who are at higher risk of fractures within the Trust. Based on their initial analysis, radiology reports were consid…

…The findings provide robust local evidence to support increased trust investment in the RDE CR service.…

…he range of potential diagnoses, the Trust, in partnership with Tata Consultancy Services (TCS), developed a chatbot to streamline history-taking, reduce…